Review of Cardiovascular Disease in Women: Awareness, Prevention, and Psychosocial Characteristics

Publisher： Karger

E-ISSN： 1424-0556|3|4|191-202

ISSN： 1422-9528

Source： Heart Drug, Vol.3, Iss.4, 2004-02, pp. : 191-202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Telmisartan: A Review of its Use in Cardiovascular Disease Prevention

By Frampton James E.

Drugs, Vol. 71, Iss. 6, 2011-04 ,pp. : 651-677

Adis International

Access to resources Recommend Favorite

Rosuvastatin: A Review of its Use in the Prevention of Cardiovascular Disease in Apparently Healthy Women or Men with Normal LDL-C Levels and Elevated hsCRP Levels

By Carter Natalie J.

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 6, 2010-12 ,pp. : 383-400

Adis International

Access to resources Recommend Favorite

Drugs for Cardiovascular Disease Prevention in Women: Implications of the AHA Guidelines - 2007 Update

By Wenger Nanette K.

Drugs, Vol. 68, Iss. 3, 2008-01 ,pp. : 339-358

Adis International

Access to resources Recommend Favorite

Pharmaceutical thrombosis prevention in cardiovascular disease

By Eriksson Mats Christensen Kjeld Lindahl Tomas L Larsson Anders

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 4, 2002-04 ,pp. : 553-563

Informa Healthcare

Access to resources Recommend Favorite

Lipid Management for the Prevention of Cardiovascular Disease

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 852-860

Bentham Science Publishers

Access to resources Recommend Favorite